Evidence vs. Access: Can Twenty-First-Century Drug Regulation Refine the Tradeoffs?

Clin Pharmacol Ther. 2012 Mar;91(3):378-80. doi: 10.1038/clpt.2011.337.

Abstract

As the pharmaceutical industry productivity crisis worsens, there are calls for regulatory changes to support innovation. At the same time, prescribers and payers desire more information about drugs at the time they are released to the market. Will new regulatory schemes be able to accommodate these disparate needs?

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Animals
  • Drug Approval / legislation & jurisprudence*
  • Drug Approval / methods*
  • Health Services Needs and Demand / legislation & jurisprudence*
  • Health Services Needs and Demand / organization & administration*
  • Humans
  • Licensure / legislation & jurisprudence*